C-Path Appoints Neuropharmacology Expert as New Vice President – Rare and Orphan Disease Programs Dr. Collin Hovinga will lead two public-private partnerships at C-Path — the Rare Disease Cures Accelerator Data and Analytics P
October 26, 2022-October 27, 2022 CDISC US Interchange, in Austin, Texas Dates: October 26-27, 2022 The 2022 CDISC US Interchange is an event consisting of workshops, training courses, and a two-day Main
October 21, 2022-October 22, 2022 International LMS Research Roundtable Dates: Friday, October 21 and Saturday, October 22 Chicago, Illinois, USA The NLMSF, SPAEN, and the LMS Community of patients
October 19, 2022-October 23, 2022 2022 IDWeek, Washington D.C Dates: October 19-23, 2022 Sessions run daily Oct. 19-23 with the closing plenary ending at 11 a.m. on Sunday, Oct. 23. IDWeek is
C-Path’s Ramona Walls Promoted to Executive Director of Data Science TUCSON, Ariz., October 20, 2022 — Critical Path Institute (C-Path) has named Ramona L. Walls, Ph.D., as Executive Director of Da
C-Path and Sturge-Weber Foundation Announce Data Sharing Agreement to Support Treatment Development for Sturge-Weber Syndrome TUCSON, Ariz., October 20, 2022 — Critical Path Institute (C-Path) and the Sturge-Weber Foundation today announced a joint colla
C-Path’s Transplant Therapeutics Consortium Receives EMA Draft Qualification Opinion for iBox Scoring System The draft EMA qualification opinion is available for public consultation until November 17, 2022 Secondary endpoint prognostic for
C-Path to Lead Pre-Consortium Aimed at Transforming, Accelerating Medical Product Development in Alpha-1 Antitrypsin Deficiency TUCSON, Ariz., Oct. 6, 2022 — Critical Path Institute (C-Path) today announced that it has recently launched a pre-consortium co
October 18, 2022 View Now | INC 2022 Scientific Meeting We’re excited to see you at the International Neonatal Consortium 2022 Scientific Meeting this fall. #INC2022 will feature